Vital Biopharmaceutical Insights and Analytics

for Experts from Experts

Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.

Learn More

FEATURED PRODUCT
How Will New Entrants Alter the Biologics Landscape in Ankylosing Spondylitis and Psoriatic Arthritis? A European Physician and Payer Perspective

There is substantial unmet need for agents with novel mechanisms of action other than TNF-alpha inhibition for the treatment of psoriatic arthritis, ankylosing spondylitis and undifferentiated spondyloarthritis... Learn More

WEBINAR ON DEMAND
European Physician and Payer Perspectives on Immune-Targeted Agents in Rheumatoid Arthritis

Recorded live on January 19, 2012 ...Learn More

View Webinar schedule and archive

Search Reports

TOP TEN REPORTS

See which reports have been searched on the most.

Go

In the Spotlight

oncology-spotlight.gif
 

Join Decision Resources Group in San Francisco on March 8th for this exciting one-day seminar.  Expert analysts from Decision Resources Group will cover a range of industry and therapeutic-specific issues, addressing the hottest topics in oncology.

Learn more.

 

Recent Reports [ view all ]

  • Alzheimer's Disease (Event Driven)

    Last Updated 3 February 2012
    The Alzheimer’s disease (AD) patient population is large and growing rapidly as... Read More

  • United States: Market Access Tracker

    Last Updated 3 February 2012
    The United States spends far more on healthcare than any other nation, and is... Read More

  • Germany: Market Access Tracker

    Last Updated 2 February 2012
    Over the past two decades, the German pharmaceutical market has undergone a... Read More

Decision Resources Group companies include: